SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

$1.8 Bn Electronic Trial Master File (eTMF) Systems Markets, 2024
[September 02, 2019]

$1.8 Bn Electronic Trial Master File (eTMF) Systems Markets, 2024


DUBLIN, Sept. 2, 2019 /PRNewswire/ -- The "Electronic Trial Master File (eTMF) Systems Market by Component (Services, Software), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations), Delivery Mode (On-Premise, Cloud-Based), and Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The electronic trial master file (eTMF) systems market is projected to reach USD 1.8 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.7%.

Growth in the eTMF systems market can be attributed primarily to the rising adoption of eTMF systems, a growing number of clinical trials, partnerships between biopharma companies & CROs, increasing funding to support clinical trials, and the growth in the R&D spending by pharma & biotech companies. Emerging countries are expected to provide significant opportunities for players in the market. However, budget constraints, data privacy issues, and a dearth of skilled professionals will challenge market growth in the coming years

Some of the prominent players operating in the electronic trial master file (eTMF) systems market include Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), and Wingspan Technology, Inc. (US).

These companies focus on organic and inorganic strategies, such as product deployments, partnerships, and solution enhancements to gain a competitive edge in the market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Electronic Trial Master File (eTMF) Systems: Market Overview
4.2 Geographic Analysis: North American eTMF Market, By Delivery Mode
4.3 Us: eTMF Systems Market Share, By Component and Delivery Mode
4.4 Geographica Snapshot of the eTMF Systems Market




5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Adoption of eTMF Systems
5.2.1.2 Rising Number of Clinical Trials
5.2.1.3 Rising Government Funding and Grants to Support Clinical Trials
5.2.1.4 Increasing R&D Expenditure By Pharma-Biotech Companies and It Expenditure Allocations
5.2.2 Restraints
5.2.2.1 Budget Constraints
5.2.3 Opportunities
5.2.3.1 Emerging Asian Markets
5.2.4 Challenges
5.2.4.1 Clinical Data Privacy
5.2.4.2 Dearth of Skilled Professionals for Operating eTMF Systems

6 eTMF Systems Market, By Component
6.1 Introduction
6.2 Services
6.2.1 Reliance on Services Will Remain High in the Coming Years, Ensuring Strong Growth in Demand
6.3 Software
6.3.1 Rising Adoption of Software is Driving High Growth in the Market


7 eTMF Systems Market, By Delivery Mode
7.1 Introduction
7.2 Cloud-Based eTMF
7.2.1 Cloud-Based eTMF Segment to Register Higher Growth During the Forecast Period
7.3 On-Premise eTMF
7.3.1 Lack of Remote Access Capabilities to Restrain the Demand for On-Premise eTMF

8 eTMF Systems Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Pharmaceutical & Biotechnology Companies are Major End-Users of eTMF Systems
8.3 Contract Research Organizations
8.3.1 Increasing Outsourcing of Clinical Trials By Pharmaceutical & Biotechnology Companies to Cros is Driving the Adoption of eTMF Systems
8.4 Other End Users

9 Electronic Trial Master File (eTMF) Systems Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Favorable Government Funding Scenario and A Large Number of Ongoing Clinical Trials are Driving the Adoption of eTMF Systems in the US
9.2.2 Canada
9.2.2.1 Favorable Regulatory Conditions and Growing Partnerships in Canada to Support Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany to Register the Highest Growth in the European eTMF Systems Market During the Forecast Period
9.3.2 UK
9.3.2.1 Growing Number of Biopharmaceutical and Medical Device Companies to Propel the Adoption of eTMF Systems in the UK
9.3.3 France
9.3.3.1 Rising Focus on Biosimilars to Create A Potential Market for eTMF Systems in France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Growing Outsourcing of Clinical Trials to Cros to Support Market Growth in China
9.4.2 Japan
9.4.2.1 Government Initiatives and Partnerships Among Pharmaceutical Companies and Cros to Drive Market Growth in Japan
9.4.3 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking of Players, 2018
10.3 Competitive Leadership Mapping
10.4 Competitive Scenario

11 Company Profiles
11.1 Veeva Systems
11.2 Oracle Corporation
11.3 Phlexglobal
11.4 Transperfect
11.5 Aurea Software
11.6 Labcorp
11.7 Epharmasolutions
11.8 Wingspan Technology
11.9 Mastercontrol
11.10 Sureclinical

For more information about this report visit https://www.researchandmarkets.com/r/87b41f

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/1-8-bn-electronic-trial-master-file-etmf-systems-markets-2024--300910160.html

SOURCE Research and Markets


[ Back To TMCnet.com's Homepage ]









Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2019 Technology Marketing Corporation. All rights reserved | Privacy Policy